Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 120Leukemia, Myeloid, Acute 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Hodgkin Disease 70Leukemia 67Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Non-Hodgkin 63Multiple Myeloma 59Myeloproliferative Disorders 57Lymphoma 54Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Leukemia, Myeloid, Accelerated Phase 46Lymphoma, Follicular 44Leukemia, Myelomonocytic, Chronic 44Leukemia, Myeloid, Chronic-Phase 44Congenital Abnormalities 43Lymphoma, Mantle-Cell 42Primary Myelofibrosis 41Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 39Burkitt Lymphoma 36Blast Crisis 36Graft vs Host Disease 35Neoplasms, Plasma Cell 34Lymphoma, Large-Cell, Immunoblastic 32Myelodysplastic-Myeloproliferative Diseases 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Waldenstrom Macroglobulinemia 21Lymphoma, T-Cell, Cutaneous 20Anemia, Refractory, with Excess of Blasts 20

Interventions

liposomal amphotericin B 2Voriconazole 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Itraconazole 2Fluconazole 2Caspofungin 2fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1Ribavirin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Tacrolimus × Myeloid × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡